Hem › Diffust storcelligt B-cellslymfom › Illinois › Chicago
Kliniska studier för Diffust storcelligt B-cellslymfom i Chicago, IL
18 studier för Diffust storcelligt B-cellslymfom söker deltagare vid platser i och runt Chicago (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
RekryterarFas 2
- Northwestern University - Feinberg School of Medicine, Chicago
- Rush University Medical Center, Chicago
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
RekryterarFas 2
- Northwestern University, Chicago
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
RekryterarFas 2
- University of Chicago Medical Center ( Site 0126), Chicago
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekryterarFas 1
- The University of Chicago Medical Center (UCMC), Chicago
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
RekryterarFas 1
- University of Chicago Comprehensive Cancer Center, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
RekryterarFas 1/2
- University of Chicago, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RekryterarFas 1/2
- University of Chicago Medical Center, Chicago
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
RekryterarObservationsstudie
- Robert H Lurie Cancer Center, Chicago
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekryterarFas 3
- Northwestern, Chicago
- University of Chicago, Chicago
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- Robert H Lurie Cancer Center, Chicago
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RekryterarFas 1
- University of Illinois at Chicago, Chicago
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
RekryterarFas 1
- Northwestern University, Chicago
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- Northwestern University, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RekryterarFas 1/2
- University of Illinois at Chicago Cancer Center, Chicago
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekryterarFas 1
- The University of Chicago Medical Center, Chicago
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
RekryterarFas 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
RekryterarFas 2
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
RekryterarFas 1
- University of Chicago, Chicago
Diffust storcelligt B-cellslymfom-studier i andra städer
- New York City, NY21 studier
- Baldwin Park, CA19 studier
- Houston, TX17 studier
- Los Angeles, CA17 studier
- Boston, MA16 studier
- Milwaukee, WI16 studier
- Nashville, TN15 studier
- Portland, OR15 studier
- Philadelphia, PA15 studier
- Durham, NC14 studier
- Dallas, TX13 studier
- Seattle, WA12 studier
Andra studier i Chicago
- Icke-småcellig lungcancer61 studier
- Bröstcancer58 studier
- Cancer (alla typer)51 studier
- Metastaserande cancer45 studier
- Prostatacancer45 studier
- Övervikt41 studier
- Lungcancer41 studier
- Äggstockscancer36 studier
- Stroke34 studier
- Kolorektal cancer33 studier
- Hjärtsvikt31 studier
- Övervikt28 studier
Från ClinicalTrials.gov, data hämtad 4 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.